Contact

Reaching a knowledgeable resource on hair restoration matters is a practical step for patients, clinicians, and researchers navigating a field governed by overlapping regulatory frameworks, clinical standards, and institutional guidelines. This page explains how inquiries are handled, what response timelines look like, and which geographic scope applies to the information published here. Understanding the structure of contact operations helps set accurate expectations before submitting a question.

Response expectations

Inquiries submitted through this resource are categorized before routing to ensure accuracy and appropriate handling. Three primary inquiry types arrive through contact channels:

1. General information requests — questions about procedures, terminology, or published clinical guidance (e.g., standards from the International Society of Hair Restoration Surgery (ISHRS))
2. Regulatory and safety framing questions — inquiries referencing FDA device classifications, such as the 510(k) pathway that governs robotic hair transplant systems and low-level laser therapy devices
3. Surgeon and clinic verification requests — questions about board certifications, state medical board licensure status, or clinic accreditation frameworks covered on pages such as Board Certifications for Hair Restoration Surgeons and Hair Restoration Clinic Accreditation

Standard response time for written inquiries is 3 to 5 business days. Inquiries requiring cross-reference with published regulatory documents — such as FDA guidance on Class II medical devices or state-specific medical practice acts — may require up to 10 business days. No inquiry is treated as a request for individualized medical or legal advice; responses address published standards, named institutional frameworks, and factual content drawn from public sources.

Inquiries that cannot be answered within the editorial scope of this resource are redirected to the appropriate named authority. For clinical questions, the ISHRS and the American Board of Hair Restoration Surgery (ABHRS) maintain their own public contact channels. For regulatory questions, the FDA's Center for Devices and Radiological Health (CDRH) publishes guidance documents at fda.gov/medical-devices.

Additional contact options

Beyond direct written inquiries, published resources on this site address the most common categories of questions in structured reference form. Patients preparing for a consultation can review Hair Restoration Consultation — What to Expect and Questions to Ask Your Hair Restoration Doctor before submitting questions that may already be answered in detail.

For questions about medication safety and regulatory status, the pages covering Finasteride for Hair Loss and Minoxidil for Hair Loss include FDA approval status, labeled indications, and named risk categories drawn from prescribing information and FDA drug databases. The Hair Loss Medications Comparison page provides a structured side-by-side framework across approved pharmacological options.

Researchers and clinicians with questions about procedural classification — for example, the distinction between follicular unit extraction and follicular unit transplantation as codified in ISHRS position statements — can reference Types of Hair Restoration Procedures or the procedure-specific pages for FUE and FUT before submitting a technical inquiry.

How to reach this office

Written inquiries are accepted through the contact form embedded on this page. The form captures the inquiry category, a description of the question, and an email address for reply. Phone contact is not available for this resource; all correspondence is handled in writing to ensure accuracy and to allow for proper source citation in responses.

For questions referencing specific regulatory documents — including 21 CFR Part 820 (FDA Quality System Regulation for medical devices) or state medical board rules governing physician supervision of hair restoration procedures — the inquiry form includes a field for citing the specific regulation or document at issue. This accelerates accurate handling.

Submissions that include a named procedure type, a geographic state, and a specific question framing receive prioritized routing. For example, an inquiry referencing scalp micropigmentation licensing requirements in California will be handled differently than a general question about Scalp Micropigmentation as a technique, because the former implicates state-level cosmetology and medical practice act boundaries.

Service area covered

This resource operates at national scope within the United States. Published content addresses federal regulatory frameworks — including FDA device classification, the Federal Trade Commission's guidelines on health advertising, and CMS coverage policies relevant to hair loss treatment — alongside state-level variation where it affects patient decision-making.

The 50 states vary in how they regulate the non-physician administration of hair restoration procedures. At least 12 states have issued specific guidance or enforcement actions distinguishing medical versus cosmetic classifications of scalp procedures, with implications for who may legally perform scalp micropigmentation or administer PRP injections. State medical board directories are publicly accessible through the Federation of State Medical Boards (FSMB).

Content on medical tourism — addressed in detail at Medical Tourism Hair Transplant Risks — covers international contexts where relevant for US-based patients evaluating procedures performed abroad. However, non-US regulatory frameworks (such as CE marking under EU MDR 2017/745 for hair restoration devices) are addressed only in comparative framing, not as primary regulatory guidance.

Geographic scope does not limit who may submit an inquiry. International readers and clinicians may submit written questions; responses will identify when a question falls outside the US regulatory scope of this resource and, where possible, will name the relevant international standards body or national health authority for redirection.

Privacy Policy

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)